云南高校图书馆联盟文献共享服务平台- PAMIDRONATE

检索规则说明：AND代表“并且”；OR代表“或者”；NOT代表“不包含”；(注意必须大写,运算符两边需空一格)

检索范例：范例一： (K=图书馆学 OR K=情报学) AND A=范并思　　　　范例二：J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual

全部期刊核心期刊 EI来源期刊 SCI来源期刊 CA来源期刊 CSCD来源期刊 CSSCI来源期刊

Role of bisphosphonates in the management of acute Charcot foot被引量：9: 《World Journal of Diabetes》2018年第7期115-126,共12页Harsh Durgia Jayaprakash Sahoo Sadishkumar Kam-alanathan Rajan Palui Kalyani Sridharan Henith Raj; Diabetes mellitus is the most common cause of Charcot neuropathy affecting foot and ankle. Acute Charcot foot(CF) presents with a red and swollen foot in co-ntrast to the painless deformed one of chronic CF. En-hanced...; 关键词：CHARCOT FOOT DIABETES MELLITUS CHARCOT neuroarthropathy BISPHOSPHONATES PAMIDRONATE

Combination treatment of bisphosphonate(pamidronate) and Quercus infectoria semipurified fraction promotes proliferation and differentiation of osteoblast cell via expression of Osterix and Runx2 marker: 《Asian Pacific Journal of Tropical Biomedicine》2018年第5期261-267,共7页Abdullah Amira Raudhah Hapidin Hermizi Abdullah Hasmah; supported by Ministry of Higher Education,Malaysia under the Fundamental Research Grant Scheme grant number 203/PPSK/6171169; Objective:To understand the effects of combination treatment of pamidronate with isolated Quercus infectoria semi-purified fraction(Qlsm-F)on human foetal osteoblast cell model(hFOB1.19 cell line)through assessment of...; 关键词：PAMIDRONATE RUNX2 OSTERIX OSTEOBLAST Quercus infectoria semi-purified fraction

Complexation of Sm^(3+) and pamidronate: A DFT study: 《Journal of Rare Earths》2015年第3期310-319,共10页Masoud Arabieh Mohammad Hassan Khodabandeh Mohammad Hossein Karimi-Jafari Carlos Platas-Iglesias Karim Zare; We reported a quantum mechanical study of the complexes formed between Sm3＋ and the bisphosphonate ligand pamidronate in aqueous solution. According to available experimental p K a values pamidronate was expected to ...; 关键词：samarium radiopharmaceutical bisphosphonates solvent effects rare earths

双膦酸盐类骨质疏松症药物: 《中国处方药》2008年第1期19-19,共1页许关煜 Sherry（编译）; 美国FDA近日发布公告，着重提示接受双膦酸盐类骨质疏松症药物（商品名和通用名分别为：Actonel／risedronate，利塞膦酸钠；Actonel＋Ca／risedronate，利塞膦酸钠＋钙；Aredia／pamidronate Disodium，帕米膦酸钠；Boniva／ibandronat...; 关键词：骨质疏松症双膦酸盐类 RISEDRONATE PAMIDRONATE IBANDRONATE 药物 DISODIUM Didronel

Randomized Double-Blind Clinical Comparison of Sodium Ibandronate and Pamidronate Disodium for Treatment of 141 Patients with Malignant Tumor Ostealgia: 《Chinese Journal of Clinical Oncology》2007年第2期103-108,共6页Guanghai Dai Shunchang Jiao Junlan Yang Shaohao Jiang Donggang Liu; OBJECTIVE To evaluate the therapeuticeffect and potential adverse ef- fects of sodium ibandronate(SI)in patients with malignant tumor ostealgia. METHODS Patients were randomly classified into two groups.Group A(SI)of ...; 关键词：osseous metastasis sodium ibandronate pamidronate-disodium bone pain.

Clinical research on zoledronic acid in treatment of pain caused by bone metastasis of malignant tumors: 《The Chinese-German Journal of Clinical Oncology》2007年第4期399-401,共3页Zhuang Yu Jun Liang Ling Peng; Objective:To evaluate the efficacy and safety of zoledronic acid for the pain caused by metastatic tumor of bone.Methods:52 patients with metastatic tumor of bone were randomly divided into two groups.The zoledronic a...; 关键词：zoledronic acid PAMIDRONATE metastatic tumor of bone bone pain

第三代双磷酸酯YM529可能是非小细胞肺癌的另一个治疗选择: 《中华医学信息导报》2007年第3期8-8,共1页安芸（摘译）; YM529是一种新发现的含氮双磷酸酯，属于第三代双磷酸酯（BP），其抗骨吸收活性比pamidronate高100倍（第二代BP）。因此YM529被用于治疗骨质疏松和高钙血症。近来的研究表明，YM529等第三代BP在体内和／或体外存在着对多种肿瘤的拮抗...; 关键词：非小细胞肺癌磷酸酯第三代 PAMIDRONATE 治疗骨吸收活性高钙血症骨质疏松

新生儿严重甲状旁腺功能亢进症:基因型/表现型间相关性和应用pamidronate作为抢救措施: 《世界核心医学期刊文摘（儿科学分册）》2005年第3期31-31,共1页Waller S. Kurzawinski T. Spitz L. W.G.Van’t Hoff 高蕊; 家族性低尿钙性高钙血症(FHH)是一种常染色体显性遗传性疾病。该病因钙敏感受体(CaSR)的基因发生杂合性突变引起。而在那些CaSR的基因纯合性突变的患儿则会罹患新生儿严重甲状旁腺功能亢进(NSHPT)症。与相对良性且无症状的:FHH不同,NSH...; 关键词：PAMIDRONATE 高钙血症甲状旁腺切除钙敏感受体生命危险表现型纯合性无症状杂合性遗传性疾病

接受静脉注射pamidronate治疗后Paget病患者骨密度增加: 《国外医学（内分泌学分册）》2003年第4期287-287,共1页; 关键词：PAGET病骨密度 PAMIDRONATE 用药剂量

钙代谢调节药帕屈膦酸二钠(Pamidronate): 《国外医药（合成药．生化药．制剂分册）》1991年第6期366-367,共2页徐积恩; 异名 Aredia 化学名 3-氨基-1-羟基亚丙基-1,1-二磷酸二钠盐药效分类钙代谢调节药开发单位 (瑞士)Ciba-Geigy 上市厂商 (瑞士)Ciba-Geigy 1989年英国首次上市药理本品抑制骨质吸收作用比氯屈膦酸二钠(Clodronate)强10倍,比依屈磷酸二钠(...; 关键词：钙代谢调节药帕屈膦酸二钠药理

PAMIDRONATE